Matricelf announce that Bayer and Prof. Tal Dvir’s lab at TAU have signed an agreement for research collaboration

This technology, developed by Prof. Dvir, is currently under development by Matricelf ( which holds the licensing rights of the technology.
The company believes that the collaboration between Bayer and Prof. Dvir’s lab, which serves as the company’s Chief Scientist, will help the further development of spinal cord implants for paralyzed patients due to spinal cord injuries and greatly advance its plans for a clinical trial.